The Gamaleya Institute is ready to file papers to Russian Health Ministry to obtain permission for research of new platforms for COVID vaccines, Institute Director Alexander Gintsburg told TASS.
[expert_review params=”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”]Earlier, Institute Deputy Director Denis Logunov said that the researchers were looking into development of a polyvalent vaccine against the coronavirus infection, based on several viral strains at the same time, for example, delta and omicron strains.
